Literature DB >> 18538342

Protection from adverse myocardial remodeling secondary to chronic volume overload in mast cell deficient rats.

Scott P Levick1, Jason D Gardner, Merrilee Holland, Martin Hauer-Jensen, Joseph S Janicki, Gregory L Brower.   

Abstract

Mast cells have diverse roles throughout the body as evidenced by their heterogeneous nature. In the heart, cardiac mast cells have been implicated in left ventricular (LV) remodeling in response to elevated myocardial stress. Accordingly, the purpose of this study was to use mast cell deficient rats (Ws/Ws) to delineate the interaction between cardiac mast cell activation and LV remodeling. LV matrix metalloproteinase (MMP) activity, fibrillar collagen, TNF-alpha levels, and LV diameter were compared in Ws/Ws and wild type (WT) rats subjected to 5 d (n=3/group) and 8 weeks (n=4/group) of aortocaval fistula-induced volume overload. In contrast to attenuation of myocardial remodeling in the Ws/Ws group: 1) MMP-2 activity was significantly increased in the WT group at 5 days; 2) there was marked degradation of the extracellular collagen matrix in WT at 5 days and 8 weeks; 3) the percent increase in LV diameter from baseline was significantly greater in WT at 2, 4, 6, and 8 weeks post-fistula; and 4) myocardial TNF-alpha levels were markedly elevated in the WT group at 5 days post-fistula. These results underscore the importance of cardiac mast cells in mediating MMP activation, collagen degradation and LV dilatation and suggest that mast cell-derived TNF-alpha plays a role in early myocardial remodeling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18538342      PMCID: PMC3272272          DOI: 10.1016/j.yjmcc.2008.04.010

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  34 in total

Review 1.  Cardiac mast cell regulation of matrix metalloproteinase-related ventricular remodeling in chronic pressure or volume overload.

Authors:  Joseph S Janicki; Gregory L Brower; Jason D Gardner; Mary F Forman; James A Stewart; David B Murray; Amanda L Chancey
Journal:  Cardiovasc Res       Date:  2005-12-22       Impact factor: 10.787

Review 2.  Mast cell homeostasis: a fundamental aspect of allergic disease.

Authors:  John J Ryan; Mohit Kashyap; Daniel Bailey; Sarah Kennedy; Kelly Speiran; Jennifer Brenzovich; Brian Barnstein; Carole Oskeritzian; Gregorio Gomez
Journal:  Crit Rev Immunol       Date:  2007       Impact factor: 2.214

3.  Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction.

Authors:  Andreas Skyschally; Petra Gres; Simone Hoffmann; Michael Haude; Raimund Erbel; Rainer Schulz; Gerd Heusch
Journal:  Circ Res       Date:  2006-12-14       Impact factor: 17.367

Review 4.  Mast cells.

Authors:  D D Metcalfe; D Baram; Y A Mekori
Journal:  Physiol Rev       Date:  1997-10       Impact factor: 37.312

5.  Protective role of mast cells in homocysteine-induced cardiac remodeling.

Authors:  Jacob Joseph; Richard H Kennedy; Sulochana Devi; Junru Wang; Lija Joseph; Martin Hauer-Jensen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-12-09       Impact factor: 4.733

6.  Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats.

Authors:  B Bozkurt; S B Kribbs; F J Clubb; L H Michael; V V Didenko; P J Hornsby; Y Seta; H Oral; F G Spinale; D L Mann
Journal:  Circulation       Date:  1998-04-14       Impact factor: 29.690

7.  c-Kit immunophenotyping and metalloproteinase expression profiles of mast cells in interstitial lung diseases.

Authors:  Samuel T Edwards; Anthony C Cruz; Samantha Donnelly; Paul F Dazin; Edward S Schulman; Kirk D Jones; Paul J Wolters; Charles Hoopes; Gregory M Dolganov; Kenneth C Fang
Journal:  J Pathol       Date:  2005-07       Impact factor: 7.996

8.  Acute and chronic hypoxia as well as 7-day recovery from chronic hypoxia affects the distribution of pulmonary mast cells and their MMP-13 expression in rats.

Authors:  Ludek Vajner; Richard Vytásek; Vera Lachmanová; Jirí Uhlík; Václava Konrádová; Jana Novotná; Václav Hampl; Jan Herget
Journal:  Int J Exp Pathol       Date:  2006-10       Impact factor: 1.925

9.  Pharmacologic inhibition of mast cell degranulation prevents left ventricular remodeling induced by chronic volume overload in rats.

Authors:  Gregory L Brower; Joseph S Janicki
Journal:  J Card Fail       Date:  2005-09       Impact factor: 5.712

10.  Insights from knock-out models concerning postischemic release of TNFalpha from isolated mouse hearts.

Authors:  J-C Reil; S Gilles; S Zahler; A Brandl; H Drexler; L Hültner; L M Matrisian; U Welsch; B F Becker
Journal:  J Mol Cell Cardiol       Date:  2006-11-13       Impact factor: 5.000

View more
  36 in total

Review 1.  Cardiac mast cells: the centrepiece in adverse myocardial remodelling.

Authors:  Scott P Levick; Giselle C Meléndez; Eric Plante; Jennifer L McLarty; Gregory L Brower; Joseph S Janicki
Journal:  Cardiovasc Res       Date:  2010-08-24       Impact factor: 10.787

2.  Estrogenic modulation of inflammation-related genes in male rats following volume overload.

Authors:  Jennifer L McLarty; Giselle C Meléndez; Scott P Levick; Shanté Bennett; Tara Sabo-Attwood; Gregory L Brower; Joseph S Janicki
Journal:  Physiol Genomics       Date:  2012-01-24       Impact factor: 3.107

3.  Estrogen inhibits mast cell chymase release to prevent pressure overload-induced adverse cardiac remodeling.

Authors:  Jianping Li; Shaiban Jubair; Joseph S Janicki
Journal:  Hypertension       Date:  2014-11-17       Impact factor: 10.190

4.  Mast Cell Inhibition Attenuates Cardiac Remodeling and Diastolic Dysfunction in Middle-aged, Ovariectomized Fischer 344 × Brown Norway Rats.

Authors:  Hao Wang; Jaqueline da Silva; Allan Alencar; Gisele Zapata-Sudo; Marina R Lin; Xuming Sun; Sarfaraz Ahmad; Carlos M Ferrario; Leanne Groban
Journal:  J Cardiovasc Pharmacol       Date:  2016-07       Impact factor: 3.105

Review 5.  Gender differences in non-ischemic myocardial remodeling: are they due to estrogen modulation of cardiac mast cells and/or membrane type 1 matrix metalloproteinase.

Authors:  Joseph S Janicki; Francis G Spinale; Scott P Levick
Journal:  Pflugers Arch       Date:  2013-02-16       Impact factor: 3.657

6.  Increased myocardial stiffness due to cardiac titin isoform switching in a mouse model of volume overload limits eccentric remodeling.

Authors:  Kirk R Hutchinson; Chandra Saripalli; Charles S Chung; Henk Granzier
Journal:  J Mol Cell Cardiol       Date:  2014-11-08       Impact factor: 5.000

7.  TNF-alpha inhibition attenuates adverse myocardial remodeling in a rat model of volume overload.

Authors:  Lynetta J Jobe; Giselle C Meléndez; Scott P Levick; Yan Du; Gregory L Brower; Joseph S Janicki
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-07       Impact factor: 4.733

8.  The emerging prominence of the cardiac mast cell as a potent mediator of adverse myocardial remodeling.

Authors:  Joseph S Janicki; Gregory L Brower; Scott P Levick
Journal:  Methods Mol Biol       Date:  2015

Review 9.  Substance P in heart failure: the good and the bad.

Authors:  Heather M Dehlin; Scott P Levick
Journal:  Int J Cardiol       Date:  2013-11-12       Impact factor: 4.164

Review 10.  Membrane-associated matrix proteolysis and heart failure.

Authors:  Francis G Spinale; Joseph S Janicki; Michael R Zile
Journal:  Circ Res       Date:  2013-01-04       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.